Treatment-free remission (TFR) has been a hot topic in CML for several years now, but it may not be for everyone. There are clinical, psychological, lifestyle and personal preference factors to consider before a patient can attempt treatment-free remission. You may also want to consider an alternative strategy to manage your CML and/or your side effects, such as dose reduction.
The aim of this webinar is to empower you with knowledge and confidence to become involved in your treatment decisions. During the webinar, the panel will explore what TFR and dose reduction are, who can try each option, and cover advantages and disadvantages.
What are long term CML treatment objectives today; are they the same goals for all?
What is dose reduction and why may it be more suitable for many than TFR?
Are there any other alternatives to TFR and dose reduction?
How can I manage my treatment expectations and my quality of life?
How important is it that you are counselled before considering attempting TFR?
Panel:
Professor Dragana Milojkovic ,Imperial college Healthcare NHS trust(
Dr Guy Hannah consultant Haematologist, Kings college Healthcare NHS trust
David FitzGerald - CML patient
Nigel Deekes - CML patient
